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A B S T R A C T
Background: Cognitive-behavioral therapy for insomnia (CBTi) is considered the standard treatment. The in-
ternet has proven to be a useful and successful tool of providing CBTi. However, few studies have investigated
the possible effect of unguided internet-delivered CBTi (ICBTi) on comorbid psychological symptoms and fa-
tigue.
Methods: Based on a randomized controlled trial, we investigated whether unguided ICBTi had an effect on
comorbid psychological symptoms. Adults with insomnia (n=181; 67% women; mean age 44.9 years [SD
13.0]) were randomized to ICBTi (n=95) or to an online patient education condition (n=86) for a nine-week
period.
Results: The results from mixed linear modelling yielded medium to large between-group effect sizes from pre- to
post-treatment for symptoms of anxiety or depression (d=−0.57; 95% CI=0.79–0.35) and fatigue (d=0.92;
95% CI=1.22–0.62). The ICBTi group was reassessed at a 6-month non-randomized follow-up, and the com-
pleting participants had on the average a significant increase (from the post-assessment) on symptoms of anxiety
or depression, while the reduction in symptoms of fatigue (on post-assessment) was maintained. However, due to
high dropout attrition and no control group data, caution should be made regarding the long-term effects. In
conclusion, the present findings show that unguided ICBTi positively influence comorbid symptoms in the short-
term, thereby emphasizing the clinical relevance of unguided ICBTi.
Trial registration: ClinicalTrials.gov identifier: NCT02261272
1. Introduction
Insomnia is the most common sleep disorder and impairs quality of
life for millions of individuals worldwide (Ohayon, 1997; Pallesen
et al., 2001). Reduced daytime functioning is an important aspect of the
insomnia diagnosis, as insomnia affects mood, social functioning, work,
cognitive functioning, and often leads to fatigue (American Psychiatric
Association, 2013). Additionally, mental illnesses, such as depression
and anxiety are commonly comorbid with insomnia (Ohayon, 2007;
Sanchez-Ortuno and Edinger, 2012). Traditionally insomnia has been
viewed as a symptom of mental illnesses, but there is a growing body of
literature indicating that insomnia may represent an independent dis-
order that can worsen and cause mental problems (Harvey, 2001). For
instance, the symptoms of insomnia often persist after the comorbid
disorder has been successfully treated, and it has been argued that this
emphasizes the necessity of a separate treatment that focuses mainly on
the symptoms of insomnia (Harvey, 2001; Sanchez-Ortuno and Edinger,
2012). Today, cognitive behavioral therapy for insomnia (CBTi) is
considered the gold standard treatment (Morin et al., 2006, Wilson
et al., 2010). CBTi has shown good results in reducing insomnia
symptoms (Okajima et al., 2011), and some studies have examined if
CBTi yields similar improvements regarding comorbid psychological
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symptoms and disorders, such as depression and anxiety (e.g., Bélanger
et al., 2016; Ho et al., 2015).
The prevalence of insomnia is steadily growing and the need for
effective treatment is urgent (Pallesen et al., 2014). To date, the
availability of CBTi is still insufficient, due to economic costs and lack
of qualified personnel offering this treatment face-to-face (Edinger and
Means, 2005). As a means of enhancing the availability of CBTi, in-
ternet-delivered CBTi (ICBTi) (e.g. Ritterband et al., 2009) has been
developed and found to be very effective in improving patients' sleep
(Cheng and Dizon, 2012; Zachariae et al., 2016). Research also in-
dicates that ICBTi may improve patient's comorbid symptoms (Ye et al.,
2015; Christensen et al., 2016). Ye et al. (2015) conducted a meta-
analysis, which included ten qualified RCTs on Internet-based CBTi
interventions. The analysis revealed overall positive results; the com-
bined effect sizes for comorbid depression and anxiety were −0.36 and
−0.35, respectively. An RCT from Australia (Christensen et al., 2016)
also examined the effect of internet-based CBTi (SHUTi) on symptoms
of depression in individuals with insomnia and sub-clinical depression.
The results at six weeks and at six months indicated that the partici-
pants who received the SHUTi treatment (n=574) had a significantly
lower level of depression symptoms, compared to participants who used
an internet-based placebo control program.
The Sleep Healthy Using the Internet (SHUTi) program is an ex-
ample of a sophisticated online adaptation of CBTi which have shown
significant results (Ritterband et al., 2009; Ritterband et al., 2012). In
the first clinical trial of SHUTi (Ritterband et al., 2009), findings in-
dicated that nearly three out of four patients were in remission six
months after treatment, which is similar to what is typically found in
face-to-face CBTi. Further, the results indicated that the SHUTi inter-
vention reduced comorbid psychological symptoms (Thorndike et al.,
2013).
In the current study, a Norwegian translated version of the SHUTi
was used to examine whether the treatment would have similar effects
outside English speaking countries. The preliminary results showed that
the SHUTi treatment improved the participants' sleep overall (Hagatun
et al., 2017). Based on the lack of knowledge about how such unguided
interventions affect comorbid disorders, the aim of the present paper
was to examine how the SHUTi intervention affected symptoms of
psychological distress and fatigue.
2. Methods
2.1. Participants and procedures
The study protocol was approved by the Regional Committees for
Medical and Health Research Ethics in Western Norway (2012/1934
REK, South East B). Details of the study procedure are reported in an-
other forthcoming paper (Hagatun et al., 2017), and therefore only
briefly summarized here: Participants were recruited through the
media, and completed an online screening before they went through a
screening interview by phone. Inclusion criteria were: minimum
18 years old and meeting the diagnostic criteria for insomnia. Exclusion
criteria were: night work, presence of another sleep disturbance or
mental problem/disorder (e.g. moderate or severe depression) that
might impair sleep. Included participants were randomly allocated to
either SHUTi or a web-based patient education condition over 9 weeks.
Participants in the SHUTi group were followed-up after 6months.
2.2. Interventions
The SHUTi program is a fully automated interactive online self-help
program (Ritterband et al., 2009), based on traditional face-to-face
CBTi. SHUTi comprises six weekly online modules, including sleep
hygiene, sleep restriction, stimulus control, and cognitive restructuring.
The program is mainly based on informative text for the participants to
read, and the treatment content, CBTi, is then elaborated and rehearsed
through interactive exercises, quizzes, animations, video vignettes, and
expert explanations. In addition, the participants are assigned home-
work for practicing the content taught in that week's core. An essential
aspect of the SHUTi program is that it provides personalised treatment
recommendations, which are automatically generated, based on the
information that each participant registers through the online sleep
diaries and questionnaires. More detailed descriptions of the SHUTi
program have been published elsewhere (Ritterband et al., 2009;
Thorndike et al., 2008).
The control intervention of the current study comprised a patient
education web site, containing information meant to resemble the kind
of information individuals with insomnia may receive when they visit a
general practitioner concerning their insomnia symptoms (Sivertsen
et al., 2010). At this site, the participants could read about the symp-
toms of insomnia, potential causal and maintaining factors, as well as
suggestions for strategies to improve sleep, including simple sleep hy-
giene strategies, as well as some of the most basic behavioral re-
commendations used in stimulus control. Hence, the information is
mainly based on the treatment principles of CBTi. Although there is
some overlap between the patient education intervention and the
SHUTi intervention, the two interventions are very different in terms of
the share volume of the self-help material and the therapeutic ap-
proach; while interactivity and personalised feedback are key elements
in the comprehensive self-help intervention in SHUTi, the information
provided in the patient education intervention was brief and static.
Hence, all information in the patient education intervention was pre-
sented as text, without any elements of interactivity or feedback, and
took about 30min to read through. The participants in the patient
education group were offered access to ICBTi (SHUTi) after completing
the first post-assessment (after nine weeks), albeit no further data were
collected from these participants.
2.3. Measurements
Symptoms of anxiety and depression were measured by The
Hospital Anxiety and Depression Scale (HADS) (Zigmond and Snaith,
1983), and the Chalder Fatigue Scale (Chalder et al., 1993) was used to
measure physical and mental symptoms of fatigue at baseline, post
treatment and the 6-month non-randomized follow-up. Only the total
HADS score was used, as research indicate that the HADS subscales'
ability to differentiate between depression and anxiety is suboptimal
(Cosco et al., 2012).
2.4. Statistical analyses
To examine the effect of the SHUTi program compared to the pa-
tient education website, a linear mixed model for repeated-measures
analysis was performed using the intention to treat principle, such that
all participants with baseline data were included in the analysis. In all,
24 of the randomized participants were not included in the analyses, as
they never completed any questionnaire (see also Fig. 1). None of these
24 participants were aware of treatment allocation and none of them
received any form of treatment. Not including these drop-outs in the
analyses is therefore not considered a threat to the internal validity of
the study. No constraints were imposed on the covariance structure for
repeated measures (type=unstructured, R-matrix only). Mixed model
analysis uses maximum likelihood estimation and can handle data that
are missing at random (MAR) on dependent variables. Although there
are no conclusive tests to prove the assumption of MAR, it is generally
considered to be a more realistic assumption as compared to missing
completely at random (MCAR). For the analysis, time (pre vs. post),
group (SHUTi vs. control), and the interaction effect time x group were
included in the model. A statistically significant (p < 0.05) interaction
effect would indicate that the effect of time was different between the
SHUTi and control group.
An additional mixed model analysis was performed including data
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from 6-month follow-up of the SHUTi participants. For this purpose,
time was modeled as a categorical variable, and backward difference
coding was adopted to compare outcomes at post- vs. pre-assessment
and 6-month follow-up vs. post-assessment. In this coding scheme, the
mean of the dependent variable for one level of the categorical variable
time is compared to the mean of the dependent variable for the prior
adjacent level of time. For three time points, two parameters are thus
estimated, and these represent the estimated mean difference of the
dependent variable between post and pre, and between 6-month follow-
up and post, respectively.
3. Results
In all, 181 adults with insomnia were included and allocated to
SHUTi (n=95) or the patient education group (n=86).
3.1. Sample characteristics
There were no differences between the SHUTi and the patient
education group on any baseline demographical characteristics. Mean
age was 44.9 years (SD 13.0). The sample comprised more women
(67%) than men, and the majority (66%) was married/living with a
partner (see Table 1).
3.2. Attrition
Questionnaires at post-assessment were not completed by 19 (20%)
of the SHUTi participants and 24 (28%) of the control group partici-
pants (χ2(1181) = 1.56, p=0.21). When comparing baseline character-
istics of participants with missing data at post-treatment, only alcohol
use was associated with missingness at follow-up. However, the corre-
lations of alcohol use score with the outcome measures (symptoms of
anxiety and depression, fatigue) were below 0.4 indicating that in-
cluding this as an auxiliary variable in the mixed model analyses would
have minimal impact (Enders, 2010). Attrition at 6-month follow-up
was high as 59 (62%) of the SHUTi participants did not complete the
questionnaire. Higher age was the only baseline characteristic that was
associated with missingness at 6-month follow-up (t(67)=−2.06,
p=0.04), but also age was not included in the analyses due to weak
correlations with the outcome variables.
3.3. Symptoms of anxiety or depression
Symptoms of anxiety or depression was significantly reduced in the
SHUTi group (Meanpre=9.72, Meanpost=6.79, dwithin=0.56; 95%
CI= 0.73–0.39), and the improvement was significantly larger com-
pared to the patient education group (dbetween=0.57; 95%
CI= 0.79–0.35) (Table 2). Among the completing SHUTi participants
at the 6-month non-randomized follow-up, the treatment gains were
slightly reduced (Mean6-month=8.42), with effect size (6-month vs.
post) dwithin=0.30 (95% CI=0.14–0.45). The difference between
baseline and 6-month non-randomized follow-up trend towards bor-
derline statistically significant (p=0.06).
Fig. 1. Participant flow.
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3.4. Fatigue
The average level of fatigue improved from pre- to post-treatment in
the SHUTi group (Meanpre=18.90, Meanpost=12.91, dwithin=1.04;
95% CI= 1.30–0.78), and was significantly greater than the patient
education group (dbetween=−0.92; 95% CI= 1.22–0.62) (Table 2).
Analyses of the 6-month follow-up data in the SHUTi group showed that
the treatment effect was relatively stable among the completing parti-
cipants (Mean6-month=13.56), with effect size (6-month vs. post)
dwithin=0.13 (95% CI= 0.02–0.28) (Table 3).
4. Discussion
The findings from the current trial indicate that the SHUTi treat-
ment had beneficial effects on psychological distress, in terms of
symptoms of depression and anxiety, as well as daytime functioning, in
terms of fatigue. Before treatment, both groups had an overall score on
psychological distress (HADS-total) just above nine points, which is the
recommended cut-off score for HADS-total (Kjærgaard et al., 2014). At
the time of treatment completion, the SHUTi group scored below the
cut-off, while the patient education group still had a mean score above
cut-off. Hence, the SHUTi group improved significantly compared to
the patient education group, indicating that the SHUTi intervention has
a positive effect on level of psychological distress in patients with in-
somnia. Additionally, the level of fatigue was reduced significantly in
the SHUTi group, compared to the patient education group.
Overall, the present findings regarding the effect of SHUTi on co-
morbid symptoms are in line with existing research indicating that CBT
for insomnia also may lead to improvements in levels of comorbid
symptoms of depression and anxiety in insomnia patients (Bélanger
et al., 2016; Manber et al., 2008; Taylor et al., 2007). Moreover, the
current results support previous research indicating that the effects of
traditional CBTi on comorbid symptoms also applies to internet-based
CBTi interventions (Christensen et al., 2016; Ye et al., 2015).
In terms of long-term efficacy, the overall results from the non-
randomized 6-month assessment indicate that the beneficial effects of
the treatment on comorbid psychological symptoms appears to be re-
latively long-lasting. One reason why symptoms of depression or an-
xiety seems to be returning somewhat at 6-month follow-up, may be
because the SHUTi program is not directly aimed at symptoms of de-
pression or anxiety. Nevertheless, the current trial revealed that the
reduction in level of fatigue at the time of treatment completion (after
nine weeks) was relatively stable at the 6-month follow-up. These
findings extend previous trials exploring the efficacy of the SHUTi in-
tervention on fatigue (e.g. Ritterband et al., 2012; Thorndike et al.,
2013), with evidence of sustained effects beyond treatment completion.
Overall, the present study indicates that the efficacy of an unguided
ICBTi treatment for insomnia goes beyond sleep outcomes; SHUTi im-
proves comorbid symptoms as well, such as fatigue and symptoms of
anxiety or depression. As many insomnia patients have such comorbid
complaints, the present study supports the clinical relevance of an un-
guided ICBTi intervention. However, several limitations should be
noted. The study only included individuals with mild symptoms of
depression, which likely resulted in a ceiling effect and the results









Age, y, mean (SD) 45.0 (12.4) 44.8 (13.7) 44.9 (13.0)
Gender (n)
Women 64% (61) 71% (61) 67% (122)
Men 36% (34) 29% (25) 33% (59)
BMIa, mean (SD) 24.7 (4.0) 24.1 (4.2) 24.4 (4.1)
Marital status (n) 46
Married/partner 64% (61) 67% (58) 66% (119)
Not married/no partner 36% (34) 33% (28) 34% (62)
Education, y, mean (SD) 16.3 (3.24) 16.6 (2.71) 16.4 (2.99)
Insomnia, duration






1–5 years 24% (23)
34.7% (33)
27.8% (26)
20% (17) 22% (40) 21.0%
(38) 34.3% (62)
28.7% (52)


















3.8 (1.7) 3.5 (1.9) 3.7 (1.8)
Smoking (n) 8% (8) 13% (11) 11% (19)
FTND=Fagerstrom Test for Nicotine Dependence.
a BMI=Body Mass Index.
b AUDIT-C=The Alcohol Use Disorders Identification Test.
Table 2
HADS and fatigue from pre-assessment and post-assessment for SHUTi participants and patient education participants.
Sleep variable
and time
SDpooled_pre SHUTi Patient education Time× group effect
N Mean (95% CI)a dwithin (95% CI) N Mean (95% CI)a dwithin (95%CI) F p-Value dbetween (95% CI)
HADS
Pre-assessment 5.21 95 9.72 (8.66, 10.77) −0.56 (−0.73, −0.39) 86 10.72 (9.61, 11.83) 0.01 (−0.13, 0.15) 23.05 < 0.001 −0.57 (−0.79, −0.35)
Post-assessment 76 6.79 (5.70, 7.88) 62 10.79 (9.61, 11.97)
Fatigue
Pre-assessment 5.75 95 18.90 (17.73, 20.06) −1.04 (−1.30, −0.78) 86 19.88 (18.66, 21.11) −0.12 (−0.27, 0.03) 36.62 < 0.001 −0.92 (−1.22, −0.62)
Post-assessment 68 12.91 (11.62, 14.12) 64 19.22 (17.83, 20.61)
a Estimated marginal means from the mixed model analyses.
Table 3
Results at 6-month follow-up of SHUTi-participants.
Estimated mean
difference. (s.e.)
p-Value SDpre dwithin (95% CI)
HADS
Post. vs. pre −2.93 (0.43) <0.001 5.39 −0.54 (−0.71, −0.37)
6-months vs. post 1.63 (0.61) 0.01 0.30 (0.14, 0.45)
6-months vs. prea −1.30 (0.68) 0.06 −0.24 (−0.48, 0.004)
Fatigue
Post. vs. pre −6.03 (0.64) <0.001 5.36 −1.13 (−1.40, −0.86)
6-months vs. post −0.70 (0.67) 0.31 0.13 (−0.02, 0.28)
6-months vs. prea −5.34 (0.75) <0.001 −1.00 (−1.20, −0.80)
Note: The results from the 6-month follow-up are based on the SHUTi group only.
a Based on an additional analysis with time coded as simple dummies.
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depression were included. On the other hand, inclusion of moderately
or severely depressed patients could have decreased the effects of the
treatment due to patients being too unwell to work with the materials.
The participants were self-recruited; measures of fatigue and symptoms
of depression or anxiety were based on self-report; and the dropout
attrition rate was high at the non-randomized 6-month follow-up. A
possible reason for the high dropout rate might be that beyond the
automatic emails, no extra effort was made to obtain the follow up data.
It should, however, be noted that available data from all participants
were included in the analyses by means of LMM, which is known to
provide valid estimates under the assumption of missing at random, and
is superior to traditional methods for dealing with missing data (Enders,
2010). Some strengths should also be noted. There are some previous
studies indicating that ICBTi treatments improve comorbid symptoms.
However, the present study extends prior results by using an unguided
treatment program, and having an active control group. Also, this is
among the few studies of unguided ICBTi outside an English/US setting.
There is still a need for further studies to gain more in depth
knowledge about the clinical efficacy of such interventions. Future
studies should consider including patients with more severe symptoms
of mental illnesses in their samples. In addition, there is a need for more
studies with longer follow-up assessments with control groups, in order
to gain further knowledge of the long-term durability of ICBTi.
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